| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 37,930 | 41,886 | ||
| Marketable securities | 119,414 | 127,061 | ||
| Prepaid expenses and other current assets | 3,701 | 3,912 | ||
| Total current assets | 161,045 | 172,859 | ||
| Total property and equipment | 11,146 | - | ||
| Less accumulated depreciation and amortization | 10,381 | - | ||
| Property and equipment, net | 765 | 970 | ||
| Operating lease right-of-use assets | 1,883 | 2,308 | ||
| Other assets | 2,046 | 2,273 | ||
| Total assets | 165,739 | 178,410 | ||
| Accounts payable | 2,102 | 4,189 | ||
| Accrued expenses | 9,008 | 6,583 | ||
| Operating lease liabilities, current | 2,209 | 2,205 | ||
| Other current liabilities | 56 | 66 | ||
| Total current liabilities | 13,375 | 13,043 | ||
| Operating lease liabilities, non-current | 387 | 959 | ||
| Preferred stock | - | 0 | ||
| Total liabilities | 13,762 | 14,002 | ||
| Common stock | 2 | 13 | ||
| Additional paid-in capital | 818,810 | 813,734 | ||
| Accumulated other comprehensive income | 100 | 16 | ||
| Accumulated deficit | -666,935 | -649,355 | ||
| Total stockholders' equity | 151,977 | 164,408 | ||
| Total liabilities and stockholders' equity | 165,739 | 178,410 | ||
RAPT Therapeutics, Inc. (RAPT)
RAPT Therapeutics, Inc. (RAPT)